Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease

As a result of increased prevalence of obesity worldwide, non-alcoholic fatty liver disease (NAFLD) has become one of the most common causes of chronic liver disease. Although most NAFLD cases remain benign, some progress to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yong, Han, Tao, Zhang, Zhi-Guang, Li, Man, Qi, Feng-Xiang, Zhang, Ying, Ji, Ying-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2017
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643779/
https://www.ncbi.nlm.nih.gov/pubmed/29063072
http://dx.doi.org/10.1016/j.cdtm.2017.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643779/
https://www.ncbi.nlm.nih.gov/pubmed/29063072
http://dx.doi.org/10.1016/j.cdtm.2017.06.003

Ejemplares similares